Farmacología y Toxicología
Departamento
Fundación Hospital Alcorcón
Alcorcón, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (16)
2023
-
Association between use of enhanced recovery after surgery protocols and postoperative complications after gastric surgery for cancer (POWER 4): a nationwide, prospective multicentre study
Cirugia Espanola, Vol. 101, Núm. 10, pp. 665-677
2022
-
Chronic coronary syndrome: practical management of antianginal drugs.
Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SE, pp. 1-10
-
Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational Study
Obesity surgery, Vol. 32, Núm. 4, pp. 1289-1299
-
Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke’s encephalopathy: Findings in preclinical models and in a postmortem human case
Frontiers in Pharmacology, Vol. 13
2021
-
Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study
Journal of Clinical Anesthesia, Vol. 74
2020
-
Association between Use of Enhanced Recovery after Surgery Protocol and Postoperative Complications in Total Hip and Knee Arthroplasty in the Postoperative Outcomes Within Enhanced Recovery after Surgery Protocol in Elective Total Hip and Knee Arthroplasty Study (POWER2)
JAMA Surgery, Vol. 155, Núm. 4
-
Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial
Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25
2015
2008
2007
-
The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats
Pediatric Research, Vol. 62, Núm. 3, pp. 255-260
-
The seek of neuroprotection: Introducing cannabinoids
Recent Patents on CNS Drug Discovery, Vol. 2, Núm. 2, pp. 131-139
2006
-
Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats
Pediatric Research, Vol. 60, Núm. 2, pp. 169-173
-
Nitric oxide synthase as a target for the prevention of hypoxic-ischemic newborn brain damage
Current Enzyme Inhibition, Vol. 2, Núm. 3, pp. 219-229
2005
-
Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy
Journal of Neuroscience Methods, Vol. 145, Núm. 1-2, pp. 205-212
-
Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia
Biology of the Neonate, Vol. 88, Núm. 4, pp. 291-298
-
The cannabinoid system and its importance in the perinatal period
Anales de Pediatria, Vol. 63, Núm. 5, pp. 433-440